We are live on ! Find out more
SIP

Stoneridge Investment Partners Portfolio holdings

AUM $152M
1-Year Est. Return 20.58%
This Fund
S&P 500
This Quarter Est. Return
+2.78%
1 Year Est. Return
+20.58%
3 Year Est. Return
+44.17%
5 Year Est. Return
+32.14%
10 Year Est. Return
+92.72%
AUM
$743M
AUM Growth
+$29.8M
Cap. Flow
+$13.8M
Cap. Flow %
1.86%
Top 10 Hldgs %
20.85%
Holding
342
New
64
Increased
88
Reduced
118
Closed
67

Top Buys

Rank Stock Value
1
APC
Anadarko Petroleum
APC
+$10.4M
2
STX icon
Seagate
STX
+$9.89M
3
BHC icon
Bausch Health
BHC
+$8.4M
4
AKAM icon
Akamai
AKAM
+$8.29M
5
YHOO
Yahoo Inc
YHOO
+$8.27M

Top Sells

Rank Stock Value
1
GM icon
General Motors
GM
+$13M
2
ZBH icon
Zimmer Biomet
ZBH
+$11.6M
3
AMAT icon
Applied Materials
AMAT
+$10.8M
4
KO icon
Coca-Cola
KO
+$8.9M
5
LOW icon
Lowe's Companies
LOW
+$8.45M

Sector Composition

Rank Sector Weight
1 Financials 18.72%
2 Healthcare 16.79%
3 Technology 15.58%
4 Consumer Discretionary 11.87%
5 Industrials 11.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OMN
251
DELISTED
OMNOVA Solutions Inc.
OMN
$242K 0.03%
39,425
-5,044
-11% -$34.2K
ASRT
252
DELISTED
Assertio
ASRT
$237K 0.03%
218
-36
-14% -$40.5K
YELL
253
DELISTED
Yellow Corporation Common Stock
YELL
$232K 0.03%
16,346
+3,508
+27% +$55.1K
ECYT
254
DELISTED
Endocyte, Inc. Common Stock
ECYT
$228K 0.03%
56,755
-7,637
-12% -$35.2K
BDC icon
255
Belden
BDC
$5.24B
$227K 0.03%
4,764
-4,312
-48% -$237K
PFE icon
256
Pfizer
PFE
$155B
$227K 0.03%
7,404
CYTK icon
257
Cytokinetics
CYTK
$10.4B
$226K 0.03%
21,586
-66,340
-75% -$651K
KERX
258
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$223K 0.03%
44,125
+6,000
+16% +$28.5K
HZN
259
DELISTED
Horizon Global Corporation
HZN
$208K 0.03%
20,012
-3,449
-15% -$31.4K
AIG icon
260
American International
AIG
$40.7B
$203K 0.03%
3,282
-2,326
-41% -$142K
ETD icon
261
Ethan Allen Interiors
ETD
$600M
$200K 0.03%
7,198
-998
-12% -$27.9K
ATW
262
DELISTED
Atwood Oceanics
ATW
$180K 0.02%
17,592
+2,400
+16% +$36.7K
LFCR icon
263
Lifecore Biomedical
LFCR
$182M
$175K 0.02%
14,804
-1,642
-10% -$20.2K
PLXP
264
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$167K 0.02%
1,868
-285
-13% -$27.3K
RYZ
265
Ryerson Holding Corp
RYZ
$1.44B
$164K 0.02%
+35,131
New +$186K
GNMK
266
DELISTED
GenMark Diagnostics, Inc
GNMK
$153K 0.02%
19,768
-1,784
-8% -$13.7K
ALPN
267
DELISTED
Alpine Immune Sciences Inc
ALPN
$150K 0.02%
+4,847
New +$165K
HUN icon
268
Huntsman Corp
HUN
$1.8B
$146K 0.02%
12,805
+1,600
+14% +$19K
IRG
269
DELISTED
Ignite Restaurant Group, Inc.
IRG
$142K 0.02%
33,802
-5,009
-13% -$20.9K
EPM icon
270
Evolution Petroleum
EPM
$133M
$132K 0.02%
27,342
-4,078
-13% -$24.7K
NNVC icon
271
NanoViricides
NNVC
$36.5M
$108K 0.01%
4,570
-754
-14% -$18.1K
ACHV icon
272
Achieve Life Sciences
ACHV
$688M
$73K 0.01%
27
-5
-16% -$21.1K
ARGS
273
DELISTED
Argos Therapeutics, Inc.
ARGS
$55K 0.01%
1,182
-169
-13% -$14.3K
GALT icon
274
Galectin Therapeutics
GALT
$315M
$46K 0.01%
28,276
-5,517
-16% -$12.6K
MBII
275
DELISTED
Marrone Bio Innovations, Inc.
MBII
$14K ﹤0.01%
12,937
-2,330
-15% -$4.99K

Similar funds

Stoneridge Investment Partners's Q4 2015 Portfolio in Review

As of Q4 2015, Stoneridge Investment Partners held 342 positions worth $743M, up 4.2% from $713M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Stoneridge Investment Partners's Q4 2015 filing shows 64 new, 88 increased, 118 reduced and 67 closed positions. Its largest new stake was Anadarko Petroleum: 169,655 shares worth $8.24M. The largest sale was General Motors, an estimated $13M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.

  • Stoneridge Investment Partners's largest Q4 2015 buy was Anadarko Petroleum: 169,655 shares worth $8.24M.
  • Stoneridge Investment Partners added most to Yahoo Inc in Q4 2015, an estimated $8.27M increase.
  • Stoneridge Investment Partners's biggest Q4 2015 reduction was General Motors, cutting an estimated $13M.
  • Stoneridge Investment Partners fully exited Coca-Cola in Q4 2015, selling an estimated $8.9M.
  • Stoneridge Investment Partners's ten largest holdings make up 21% of its $743M portfolio in Q4 2015.
  • Stoneridge Investment Partners opened 64 new positions and closed 67 in Q4 2015.
  • Stoneridge Investment Partners's portfolio value rose 4.2% quarter-over-quarter to $743M.

Based on Stoneridge Investment Partners's 13F filing for Q4 2015, filed 4 Feb 2016.